These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The effect of lithium on the "on-off" phenomenon in parkinsonism. Coffey CE; Ross DR; Ferren EL; Bragdon AC; Hurwitz BJ; Olanow CW Adv Neurol; 1983; 37():61-73. PubMed ID: 6858779 [No Abstract] [Full Text] [Related]
11. On-off effects in Parkinson's disease: a controlled investigation of ascorbic acid therapy. Reilly DK; Hershey L; Rivera-Calimlim L; Shoulson I Adv Neurol; 1983; 37():51-60. PubMed ID: 6344591 [TBL] [Abstract][Full Text] [Related]
12. [Problems in the administration of L-DOPA (author's transl)]. Ferrari E Riv Patol Nerv Ment; 1974 Aug; 95(4):239-50. PubMed ID: 4283417 [No Abstract] [Full Text] [Related]
13. Controversies in the treatment of Parkinson's disease. Hershey LA Ration Drug Ther; 1985 Feb; 19(2):1-4. PubMed ID: 4048474 [No Abstract] [Full Text] [Related]
14. The clinical physiology of side effects in long-term L-DOPA therapy. Barbeau A Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234 [No Abstract] [Full Text] [Related]
15. Letter: Dyskinesias during levodopa therapy. Tolosa ES; Maritn WE; Cohen HP Lancet; 1975 Jun; 1(7921):1381-2. PubMed ID: 48968 [No Abstract] [Full Text] [Related]
16. L-dopa, parkinsonism, and involuntary movements. Mayer RF Trans Am Neurol Assoc; 1974; 99():163-6. PubMed ID: 4463527 [No Abstract] [Full Text] [Related]
18. Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease. Sweet RD; McDowell FH Neurology; 1974 Oct; 24(10):953-6. PubMed ID: 4472237 [No Abstract] [Full Text] [Related]
19. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]